ALLIANCE A071401

Primary Category:

Treatment Protocols

Disease Category:

Brain

Status:

Open

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas with SMO/ AKT/ NF2/CDK Pathway Mutations

NCT#02523014

A071401 Cohorts NF2, CDKN2A, CDK4, CDK6, CCND1, CCND2, CCND3, and CCNE1 Cohort (Abemaciclib Cohort) will close to new patient registration (Step 1) to abemaciclib cohort, effective October 3, 2022